News

A new study from the Steno Diabetes Center, presented at last month’s EASD conference, shows the value of multifactorial intervention in type 2 diabetes. Improvement in more than one risk factor had a signif...

Reporting at the EASD’s 57th Annual Meeting, a team at the Karolinska Institute has found that mental health issues like depression and anxiety affect not just the person with type 1 diabetes, but their fami...

Psychosocial care and individualisation were common themes from the new ADA/EASD consensus report presented at the 57th EASD Annual Meeting 2021.

To kick off its latest initiative, ‘The briefing room’, EASD e-Learning has brought together a stellar panel to discuss one of the most urgent and significant issues facing diabetes today: obesity.

Researchers in Finland have used the latest genome-analysis technology to discover some rare gene variants that contribute to severe diabetic retinopathy.

It may be worth paying more attention to both degree of insulin resistance and fasting insulin levels when monitoring the health of people with type 2 diabetes, according to new research presented at the EAS...

A further analysis of the STEP 2 trial results presented at last week’s 57th EASD Annual Meeting showed promising glucose metabolism results for the GLP-1 receptor agonist, with two thirds of participants as...

Results from the EMPEROR-Preserved trial give further testament to the benefits offered by SGLT-2 inhibitors in diabetes care.

The brain is a voracious consumer of glucose and for many the effects upon it of a lack of blood sugar are among the most concerning aspects of life with diabetes. For our latest ‘Long and short of it’, Prof...

The value attached to real-world evidence (RWE) in clinical decision making has increased significantly over recent years. Using examples taken from diabetes treatment, our latest module – launching today – ...

In his second module for our ‘Diabetic neuropathy’ course, Professor Solomon Tesfaye takes a closer look at the pathophysiology of diabetic peripheral neuropathy and surveys the treatments currently available.

Centennial celebrations of insulin’s discovery have, with good reason, tended to dwell on progress and innovation in its design and usage. But what about the more basic challenges still faced by so many user...

What happened when we asked our authors to list the top five research questions in their area of specialisation? The answer is a new series of short films, starting today.

The close link between obesity and type 2 diabetes is well established, but our latest module digs deeper – exploring the wider relationship with ethnicity, age and complications, cardiovascular disease in p...

In the wake of the diabetes pandemic, prevalence of non-alcoholic fatty liver disease (NAFLD) is on the rise. Following his first module about the epidemiology, pathophysiology and diagnosis of NAFLD, Profes...

Modules on the EASD e-Learning platform have now received formal educational accreditation for continuous professional development (CPD) from the UK’s Royal College of General Practitioners (RCGP), it was an...

Though not much talked about, fear of hypoglycaemia can have devastating implications for the wellbeing and health of people with diabetes. In his new module, Professor Frank Snoek examines the challenges fe...

The 57th Annual Meeting of the European Association for the Study of Diabetes (EASD) opens tomorrow. Once again, this year’s conference will be virtual – and there are some new ‘live’ twists to tempt you in ...

Prediabetes and type 2 diabetes are on the rise in young people, so finding ways to prevent them early in life is becoming ever more urgent. Delegates at the American Diabetes Association 81st Scientific Ses...

A draft consensus report on the management of type 1 diabetes in adults from the American Diabetes Association (ADA) and European Association for the Study of Diabetes is now available. In our latest ‘The lo...

Action to take before, during and after exercise for people with type 1 diabetes was the focus of a presentation at the American Diabetes Association (ADA) 81st Scientific Sessions.